
Mark Sabag
Executive Vice President, International Markets Commercial
Mark Sabag was appointed Executive Vice President, International Markets Commercial, in 2021, leading all commercial activities in a region comprising 27 markets, including key Latin America countries, Russia and Eastern Europe, Israel, the Middle East, Africa, Asia-Pacific, China and Japan.
The International Markets commercial unit manages a high-quality portfolio of specialty medicines, generics and biopharmaceuticals, active pharmaceutical ingredients (API) and over-the-counter (OTC) products - with full end-to-end profit and loss (P&L) accountability.
Prior to that Mark served as Executive Vice President, Chief Human Resources Officer before his role was expanded to include Global Communications, Brand and ESG. Leading up to that he held several senior Human Resources positions for Teva’s International Group and Mergers and Acquisitions (M&As).
Before joining Teva in 2006, he held several senior global human resources roles at Intel Corporation.
Mark Sabag received a B.A. in economics and business management from Haifa University.

Kåre Schultz
President and Chief Executive Officer, Member of the Board of Directors

Richard Daniell
Executive Vice President, European Commercial

Dr. Sven Dethlefs
Executive Vice President, North America Commercial

Eric Drapé
Executive Vice President, Global Operations

Dr. Hafrun Fridriksdottir
Executive Vice President, Global R&D

Galia Inbar
Executive Vice President, Chief Human Resources Officer and Head of Global Communications and Brand

Eli Kalif
Executive Vice President, Chief Financial Officer (CFO)

Eli Shani
Executive Vice President, Global Marketing and Portfolio

David M. Stark
Executive Vice President, Chief Legal Officer

Nir Baron
Senior Vice President, Chief Internal Auditor

Lori Queisser
Sr. Vice President & Global Compliance Officer
At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:
Copyright © 2022 Teva Pharmaceutical Industries Ltd.